SpaceX may be the biggest IPO ever, but Morningstar says it is overvalued by half and the smart investors will wait out the hype and buy later

Morningstar's analyst warns that SpaceX's anticipated IPO is significantly overvalued, with fair value estimated at roughly half the expected offering price. The analysis suggests patient investors should wait for post-IPO volatility and insider selling windows to accumulate shares at more reasonable valuations rather than buying into initial hype.

SpaceX's potential IPO represents one of the largest capital raises in market history, reflecting investor enthusiasm for the company's space exploration and satellite internet ambitions. However, Morningstar's valuation work suggests the market is pricing in exceptionally optimistic scenarios that may not materialize, creating a disconnect between hype and fundamental value. This pattern is familiar in high-growth tech IPOs, where scarcity of shares and retail fervor drive opening prices disconnected from cash flow fundamentals.

The analyst's recommendation to wait reflects established market wisdom about IPO dynamics. Initial public offerings typically experience elevated valuations driven by pent-up demand and limited float, but prices often normalize once supply increases and insider lock-up periods expire. Morningstar's 50% overvaluation estimate suggests significant downside risk for buyers at launch prices. This perspective challenges the conventional wisdom that early IPO entry guarantees premium returns.

For SpaceX specifically, valuation depends heavily on assumptions about Starlink's revenue growth, government contracts, and long-term profitability timelines—all inherently uncertain. Early IPO investors bear concentration risk betting on management's execution against multiple technical and commercial hurdles. The analyst's framework suggests waiting for validation of business assumptions through actual financial results reported post-IPO.

Looking ahead, investors should monitor SpaceX's lockup expiration dates and quarterly earnings guidance closely. Insider selling windows historically coincide with meaningful price corrections as supply hits the market. Establishing positions after this volatility resolves offers better risk-adjusted returns than chasing opening-day momentum.

• →Morningstar values SpaceX at approximately 50% below anticipated IPO pricing, indicating significant overvaluation
• →Insider lock-up expirations and post-IPO volatility may create better buying opportunities than launch-day pricing
• →SpaceX's valuation depends on uncertain assumptions about Starlink growth and government contract revenue streams
• →Early IPO buyers face concentration risk in exchange for potential liquidity premiums available only at open
• →Patient capital positioning after initial hype dissipates historically outperforms momentum-driven IPO investing